Jialu Xu

Jialu Xu

Auto-generated profile, based on publicly available information

Jialu Xu

Laboratory for Biomaterial and Immunoengineering, Institute of Functional Nano and Soft Materials (FUNSOM), Soochow University, Suzhou, Jiangsu 215123, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
JXJialu Xu
Jialu Xu
QMQingle Ma
Qingle Ma
YZYue Zhang
Yue Zhang
ZFZiying Fei
Ziying Fei
YSYifei Sun
Yifei Sun
Chao WangChao Wang
Chao Wang
Microbe-based cancer immunotherapy has recently emerged as a hot topic for cancer treatment. However, serious limitations remain including infection associated side-effect and unsatisfactory outcomes in clinic trials. Here, we fabricate different sizes of nano-formulations derived from yeast cell wall (YCW NPs) by differential centrifugation. The induction of anticancer immunity of our formulations appears to inversely correlate with their size due to the ability to accumulate in tumor-draining lymph node (TDLN). Moreover, we use a percolation model to explain their distribution behavior toward TDLN. The abundance and functional orientation of each effector component are significantly improved not only in the microenvironment in tumor but also in the TDLN following small size YCW NPs treatment. In combination with programmed death-ligand 1 (PD-L1) blockade, we demonstrate anticancer efficiency in melanoma-challenged mice. We delineate potential strategy to target immunosuppressive microenvironment by microbe-based nanoparticles and highlight the role of size effect in microbe-based immune therapeutics.

25 July 2024 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
JXJialu Xu
Jialu Xu
YYYue Yu
Yue Yu
YZYue Zhang
Yue Zhang
HDHuaxing Dai
Huaxing Dai
QYQianyu Yang
Qianyu Yang
Chao WangChao Wang
Chao Wang

25 September 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
Qin FanQin Fan
Qin Fan
QMQingle Ma
Qingle Ma
JBJingyu Bai
Jingyu Bai
JXJialu Xu
Jialu Xu
ZFZiying Fei
Ziying Fei
Chao WangChao Wang
Chao Wang
An implantable blood clot–based cancer vaccine is developed for enhanced cancer immunotherapy.

23 August 2024 in Science Advances
Verified
Journal Article
Open access
YZYue Zhang
Yue Zhang
CZChenmeng Zhou
Chenmeng Zhou
BTBo Tian
Bo Tian
JXJialu Xu
Jialu Xu
XWXiaoyu Wang
Xiaoyu Wang
Chao WangChao Wang
Chao Wang
Introducing specific strains of probiotics into the gut microbiome is a promising way to modulate the intestinal microbiome to treat various health conditions clinically. However, oral probiotics typically have a temporary or limited impact on the gut microbiome and overall health benefits. Here, we reported a 3D printed cellulose-derived spiral tube-like scaffold that enabled high efficacy of the oral delivery of probiotics. Benefiting from the unique surface pattern, this system can effectively extend the retention time of loaded probiotics in the gut without invading nearby tissues, provide a favorable environment for the survival and long-term colonization of loaded probiotics, and influence the intestinal ecosystem as a dietary fiber after degradation. We demonstrate Roseburia intestinalis -loaded scaffold exerts noticeable impacts on the regulation of the gut microbiome to treat various gut-related diseases, including obesity and inflammatory bowel disease; thus, we provide a universal platform for oral delivery of probiotics.

28 February 2021 in Exploration of Medicine
Verified
Journal Article
Open access
PDF file
JXJialu Xu
Jialu Xu
Chao WangChao Wang
Chao Wang
In recent years, cancer immunotherapy has received unprecedented attention due to the clinical achievements. The applications of biomedical engineering and materials science to cancer immunotherapy have solved the challenges caused by immunotherapy to a certain extent. Among them, cell-derived vesicles are natural biomaterials chosen as carriers or immune-engineering in view of their many unique advantages. This review will briefly introduce the recent applications of cell-derived vesicles for cancer immunotherapy.